Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [06/08/2026 11:45 PDT] Evolus, Inc. (NASDAQ:EOLS), Up By 100% ($6.18) From $6.18 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/28/2026 06:41 PDT] sector Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.
• [05/07/2026 07:04 PDT] EOLS Expected to Trade Up After Bullish Patterns Develop
• [05/05/2026 06:37 PDT] EOLS Expected to Trade Up Short Term
• [05/04/2026 14:55 PDT] Evolus, Inc. (NASDAQ:EOLS), Up By 100% ($4.93) From $4.93 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/22/2026 09:51 PDT] Evolus, Inc. (NASDAQ:EOLS), Up By 100% ($4.27) From $4.27 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/22/2026 09:51 PDT] Evolus, Inc. (NASDAQ:EOLS), Up By 100% ($4.55) From $4.55 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/22/2026 04:01 PDT] EOLS Expected to Trade Up After Bullish Patterns Develop
• [04/17/2026 07:25 PDT] EOLS Expected to Trade Up After Bullish Patterns Develop
• [04/14/2026 09:25 PDT] EOLS Expected to Trade Up After Bullish Patterns Develop